Cooper Companies (COO) Rating Lowered to C at TheStreet
Other analysts also recently issued research reports about the stock. Jefferies Group reiterated a buy rating and issued a $285.00 target price on shares of Cooper Companies in a report on Friday. Stifel Nicolaus reiterated a buy rating and issued a $265.00 target price (down previously from $275.00) on shares of Cooper Companies in a report on Friday, December 8th. Raymond James Financial reiterated a buy rating and issued a $265.00 target price on shares of Cooper Companies in a report on Monday, December 4th. Zacks Investment Research upgraded shares of Cooper Companies from a hold rating to a buy rating and set a $257.00 target price for the company in a report on Tuesday, November 14th. Finally, Oppenheimer set a $265.00 target price on shares of Cooper Companies and gave the company a hold rating in a report on Friday. Eight equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Cooper Companies presently has an average rating of Hold and a consensus price target of $267.50.
Cooper Companies (NYSE:COO) opened at $251.43 on Thursday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.26 and a current ratio of 2.41. Cooper Companies has a 1-year low of $192.24 and a 1-year high of $260.26. The firm has a market cap of $12,330.00, a price-to-earnings ratio of 72.25, a price-to-earnings-growth ratio of 2.02 and a beta of 0.61.
In related news, CEO Robert S. Weiss sold 32,500 shares of the stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $224.70, for a total transaction of $7,302,750.00. Following the completion of the transaction, the chief executive officer now owns 119,111 shares in the company, valued at $26,764,241.70. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Allan E. Rubenstein sold 6,450 shares of the stock in a transaction dated Friday, January 12th. The shares were sold at an average price of $228.79, for a total transaction of $1,475,695.50. Following the transaction, the director now owns 8,628 shares of the company’s stock, valued at approximately $1,974,000.12. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 54,385 shares of company stock valued at $12,289,463. 1.60% of the stock is owned by company insiders.
Institutional investors and hedge funds have recently bought and sold shares of the stock. BB&T Investment Services Inc. grew its position in Cooper Companies by 71.0% during the fourth quarter. BB&T Investment Services Inc. now owns 542 shares of the medical device company’s stock valued at $119,000 after buying an additional 225 shares during the period. Canada Pension Plan Investment Board bought a new position in Cooper Companies during the third quarter worth about $163,000. Virtue Capital Management LLC bought a new position in Cooper Companies during the fourth quarter worth about $195,000. Ballentine Partners LLC bought a new position in Cooper Companies during the third quarter worth about $223,000. Finally, CAPROCK Group Inc. bought a new position in Cooper Companies during the fourth quarter worth about $222,000. Institutional investors own 97.45% of the company’s stock.
Cooper Companies Company Profile
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.